Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 193

VisasQ to visit Tokyo listing

Tokyo’s Mothers Market has approved an IPO for the business knowledge-sharing platform that would allow CyberAgent, DA Consortium and Mizuho Bank to exit.

Feb 6, 2020

ALD NanoSolutions forges ahead with $20m

CU Boulder spinout ALD NanoSolutions has merged with its peer Forge Nano, with new merged company securing $20m from a range of corporates.

Feb 5, 2020

BrickVest rests at Patrizia

Patrizia has paid an undisclosed amount to buy the real estate investment platform, whose investors included Aareal Bank and Berlin Hyp.

Feb 4, 2020

Monivent nears $2.1m IPO

Chalmers University of Technology-founded baby ventilation monitor developer Monivent will join the Spotlight Stock Market in an IPO where 60% of shares have advance subscriptions in place.

Feb 4, 2020

Passage Bio reaches IPO stage

University of Pennsylvania-linked CNS disorder-focused drug developer Passage Bio has filed to raise up to $125m having raised $226m in funding.

Feb 4, 2020

Revolution to make waves with IPO

The cancer therapy developer is set to raise between $140m and $160m in its initial public offering, following $226m in funding.

Feb 4, 2020

Revolution sets range for IPO

The Sanofi-backed cancer therapy developer is set to raise between $140m and $160m in its initial public offering following $226m in funding.

Feb 4, 2020

LexisNexis extends $480m for Emailage acqusition

Wipro Ventures is set to exit email security software provider Emailage in an acquisition by LexisNexis Risk Solutions, which is paying a reported $480m.

Feb 4, 2020

FTC parries Harry’s acquisition plans

Eight months after Grace Beauty-backed Harry’s agreed to an acquisition by Edgewell for $1.37bn, the US antitrust agency has sued to block the deal on competition grounds.

Feb 4, 2020

Passage Bio reaches IPO stage

The CNS disorder-focused drug developer has filed to raise up to $125m having raised $226m in funding from backers including Eli Lilly and Access Industries.

Feb 4, 2020
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here